Angelo Pirozzi(@angelopirozzi3) 's Twitter Profile Photo

-T cells🎯 .2 in pretreated advanced

👉2 phase I/Ib trials w 24 pts
👉79% ≥2 previous systemic lines
❌️ORR 16.7%
✅️DCR 70.8%
❌️mPFS 3.3 mths
✅️mOS 10.0 mths
✅️mDoR 9.5 mths
ascopubs.org/doi/10.1200/JC…


Journal of Clinical Oncology

#CAR-T cells🎯#claudin18.2 in pretreated advanced #PDAC

👉2 phase I/Ib trials w 24 pts
👉79% ≥2  previous systemic lines
❌️ORR 16.7%
✅️DCR 70.8%
❌️mPFS 3.3 mths
✅️mOS 10.0 mths
✅️mDoR 9.5 mths 
ascopubs.org/doi/10.1200/JC…

#celltherapy #pancreaticcancer 
@JCO_ASCO
account_circle
Giovanni Marchegiani(@Gio_Marchegiani) 's Twitter Profile Photo

🪐 The REDISCOVER Guidelines for BR and LA PDAC - part 2 🚀

💡 Unanswered questions / future perspectives include

🥀 Resection of SMA !?
🧐 Management of LA PDAC in unfit for chemo / elevated CA 19.9
💉 Numbers of chemo cycles
💥 Ablation therapies role

link.springer.com/article/10.100…

🪐 The REDISCOVER Guidelines for BR and LA PDAC - part 2 🚀

💡 Unanswered questions / future perspectives include

🥀 Resection of SMA !?
🧐 Management of LA PDAC in unfit for chemo / elevated CA 19.9
💉 Numbers of chemo cycles
💥 Ablation therapies role

link.springer.com/article/10.100…
account_circle
Michael Yan, MD MPH(@MichaelYanMD) 's Twitter Profile Photo

Adjuvant SBRT for PDAC is tolerable, no grade 3 toxicities as per SPARTA trial. Shorter regimen and more tolerable, is there a diminishing role for CRT?

Adjuvant SBRT for PDAC is tolerable, no grade 3 toxicities as per SPARTA trial. Shorter regimen and more tolerable, is there a diminishing role for CRT? #ESTRO2024
account_circle
Krishan Jethwa(@KrishanJethwa) 's Twitter Profile Photo

🚨🚨RTOG 0848🚨🚨

Anatomically resectable PDAC randomized postoperatively
1st randomization:

Gemcitabine +/- erlotinib (no benefit with erlotinib)

🔥2nd Randomization🔥
+/- Chemoradiation, 50.4 Gy/28 fx + cape

✅⬆️ DFS w/ ☢️
✅N0, ⬆️DFS and OS (5y 48% vs 29%) w/ ☢️

🚨🚨RTOG 0848🚨🚨

Anatomically resectable PDAC randomized postoperatively
 1st randomization:

Gemcitabine +/- erlotinib (no benefit with erlotinib)

🔥2nd Randomization🔥
+/- Chemoradiation, 50.4 Gy/28 fx + cape

✅⬆️ DFS w/ ☢️
✅N0, ⬆️DFS and OS (5y 48% vs 29%) w/ ☢️
#asco24
account_circle
Lola Lozano(@mdlozanoe) 's Twitter Profile Photo

'When the most awful is reminiscent of something beautiful': EUS-FNA, PDAC (an ugly epithelial cell 'hanging' from a fragment of fibrosis (which is very often associated with these tumors)
Cytopathology, What else?

'When the most awful is reminiscent of something beautiful': EUS-FNA, PDAC (an ugly epithelial cell 'hanging' from a fragment of fibrosis (which is very often associated with these tumors) 
Cytopathology, What else? #cytopath #pathResidents
account_circle
Michael Schmid(@M_C_Schmid) 's Twitter Profile Photo

🤩 Excellent Cancer Seminar today presented by super ECR Yuliana Astuti discussing macrophage heterogeneity in metastasis. Great talk and lots of exciting data! 👏🏻👏🏻👏🏻

🤩 Excellent Cancer Seminar today presented by super ECR Yuliana Astuti discussing macrophage heterogeneity in #PDAC metastasis. Great talk and lots of exciting data! 👏🏻👏🏻👏🏻
account_circle
avidresearch(@avidresearch) 's Twitter Profile Photo

$CTMX $JANX plots side by side. Obvious that some cancers like CRC are harder but tumor shrinkage seen in esophageal and NSCLC where higher doses could see some responses. PDAC obviously the most promising.

$CTMX $JANX plots side by side. Obvious that some cancers like CRC are harder but tumor shrinkage seen in esophageal and NSCLC where higher doses could see some responses. PDAC obviously the most promising.
account_circle
BionicM_official(@BionicM_offic) 's Twitter Profile Photo

🎉Breaking News Post-Memorial Holiday!🎉
We are thrilled to announce that Bio Leg™ has been approved by PDAC with 5 codes!
This advances our technology's accessibility in the U.S. market and pushes industry boundaries.

🎉Breaking News Post-Memorial Holiday!🎉
We are thrilled to announce that Bio Leg™ has been approved by PDAC with 5 codes!
This advances our technology's accessibility in the U.S. market and pushes industry boundaries.
#BionicM #BioLeg #Prosthetics #PDACApproved #Healthcare
account_circle
UNC Pancreas Center(@UNCPancreas) 's Twitter Profile Photo

Terrific talks on research keep rolling UNC Lineberger Scientific Symposium w/ UNC Lineberger's Kirsten Bryant (@bryant_kl), PhD, John Morris (@johnpmorrisiv), PhD, and Channing Der (@derlabunc), PhD. Autophagy inhibition, PDAC Progression & KRAS Targeting!

Terrific talks on #PancreaticCancer research keep rolling @UNC_Lineberger Scientific Symposium w/ UNC Lineberger's Kirsten Bryant (@bryant_kl), PhD, John Morris (@johnpmorrisiv), PhD, and Channing Der (@derlabunc), PhD. Autophagy inhibition, PDAC Progression & KRAS Targeting!
account_circle
quantumup(@Quantumup1) 's Twitter Profile Photo

Needham⬆️ $RVMD $46 was $36/Buy~after +VE preclin data in G13X/Q61X supported by clin activity in 3 pts w/ non-G12C mutations in PDAC/CRC/melanoma — the preclin data support that the combo of RMC-6236/RMC-6291 can generate meaningful improvement in durability +⬆️response rates:

Needham⬆️ $RVMD $46 was $36/Buy~after +VE preclin data in G13X/Q61X supported by clin activity in 3 pts w/ non-G12C mutations in PDAC/CRC/melanoma — the preclin data support that the combo of RMC-6236/RMC-6291 can generate meaningful improvement in durability +⬆️response rates:
account_circle
Michael Horner(@michaelbhorner) 's Twitter Profile Photo

Invest in a uranium explorer-turned-gold explorer’s private placement. Get the warrants. Attend a PDAC presentation at 4 o’clock in a mostly empty room. Probably a project in a country you’ve never heard of. Read the tweet of some anonymous account pumping that stock you’re down

Invest in a uranium explorer-turned-gold explorer’s private placement. Get the warrants. Attend a PDAC presentation at 4 o’clock in a mostly empty room. Probably a project in a country you’ve never heard of. Read the tweet of some anonymous account pumping that stock you’re down
account_circle